Year |
Citation |
Score |
2009 |
McCutcheon JE, White FJ, Marinelli M. Individual differences in dopamine cell neuroadaptations following cocaine self-administration. Biological Psychiatry. 66: 801-3. PMID 19539267 DOI: 10.1016/j.biopsych.2009.04.018 |
0.818 |
|
2009 |
Sidiropoulou K, Lu FM, Fowler MA, Xiao R, Phillips C, Ozkan ED, Zhu MX, White FJ, Cooper DC. Dopamine modulates an mGluR5-mediated depolarization underlying prefrontal persistent activity. Nature Neuroscience. 12: 190-9. PMID 19169252 DOI: 10.1038/Nn.2245 |
0.844 |
|
2006 |
Perez MF, White FJ, Hu XT. Dopamine D(2) receptor modulation of K(+) channel activity regulates excitability of nucleus accumbens neurons at different membrane potentials. Journal of Neurophysiology. 96: 2217-28. PMID 16885524 DOI: 10.1152/jn.00254.2006 |
0.757 |
|
2006 |
Marinelli M, Rudick CN, Hu XT, White FJ. Excitability of dopamine neurons: modulation and physiological consequences. Cns & Neurological Disorders Drug Targets. 5: 79-97. PMID 16613555 DOI: 10.2174/187152706784111542 |
0.607 |
|
2006 |
Peterson JD, Wolf ME, White FJ. Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 3164-8. PMID 16554467 DOI: 10.1523/JNEUROSCI.2375-05.2006 |
0.808 |
|
2005 |
Couceyro PR, Evans C, McKinzie A, Mitchell D, Dube M, Hagshenas L, White FJ, Douglass J, Richards WG, Bannon AW. Cocaine- and amphetamine-regulated transcript (CART) peptides modulate the locomotor and motivational properties of psychostimulants. The Journal of Pharmacology and Experimental Therapeutics. 315: 1091-100. PMID 16099925 DOI: 10.1124/Jpet.105.091678 |
0.468 |
|
2005 |
McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, Nestler EJ. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proceedings of the National Academy of Sciences of the United States of America. 102: 9377-81. PMID 15967985 DOI: 10.1073/Pnas.0503584102 |
0.817 |
|
2005 |
Nasif FJ, Hu XT, White FJ. Repeated cocaine administration increases voltage-sensitive calcium currents in response to membrane depolarization in medial prefrontal cortex pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3674-9. PMID 15814798 DOI: 10.1523/JNEUROSCI.0010-05.2005 |
0.742 |
|
2005 |
Hu XT, Ford K, White FJ. Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 916-26. PMID 15726118 DOI: 10.1038/sj.npp.1300654 |
0.73 |
|
2005 |
Dong Y, Nasif FJ, Tsui JJ, Ju WY, Cooper DC, Hu XT, Malenka RC, White FJ. Cocaine-induced plasticity of intrinsic membrane properties in prefrontal cortex pyramidal neurons: adaptations in potassium currents. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 936-40. PMID 15673674 DOI: 10.1523/JNEUROSCI.4715-04.2005 |
0.841 |
|
2005 |
Hu XT, Dong Y, Zhang XF, White FJ. Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons. Journal of Neurophysiology. 93: 1406-17. PMID 15590733 DOI: 10.1152/jn.00771.2004 |
0.761 |
|
2005 |
Nasif FJ, Sidiropoulou K, Hu XT, White FJ. Repeated cocaine administration increases membrane excitability of pyramidal neurons in the rat medial prefrontal cortex. The Journal of Pharmacology and Experimental Therapeutics. 312: 1305-13. PMID 15574686 DOI: 10.1124/Jpet.104.075184 |
0.828 |
|
2004 |
Hu XT, Basu S, White FJ. Repeated cocaine administration suppresses HVA-Ca2+ potentials and enhances activity of K+ channels in rat nucleus accumbens neurons. Journal of Neurophysiology. 92: 1597-607. PMID 15331648 DOI: 10.1152/Jn.00217.2004 |
0.778 |
|
2004 |
Dong Y, Cooper D, Nasif F, Hu XT, White FJ. Dopamine modulates inwardly rectifying potassium currents in medial prefrontal cortex pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3077-85. PMID 15044547 DOI: 10.1523/JNEUROSCI.4715-03.2004 |
0.826 |
|
2003 |
Marinelli M, Cooper DC, Baker LK, White FJ. Erratum to: Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology. 170: 334. PMID 29356872 DOI: 10.1007/s00213-003-1674-9 |
0.741 |
|
2003 |
Brandon CL, Marinelli M, White FJ. Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons. Biological Psychiatry. 54: 1338-44. PMID 14675797 DOI: 10.1016/S0006-3223(03)00787-X |
0.832 |
|
2003 |
Koeltzow TE, White FJ. Behavioral depression during cocaine withdrawal is associated with decreased spontaneous activity of ventral tegmental area dopamine neurons. Behavioral Neuroscience. 117: 860-5. PMID 12931970 DOI: 10.1037/0735-7044.117.4.860 |
0.848 |
|
2003 |
Peterson JD, Wolf ME, White FJ. Impaired DRL 30 performance during amphetamine withdrawal. Behavioural Brain Research. 143: 101-8. PMID 12842301 DOI: 10.1016/S0166-4328(03)00035-4 |
0.748 |
|
2003 |
Marinelli M, Cooper DC, Baker LK, White FJ. Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology. 168: 84-98. PMID 12721782 DOI: 10.1007/s00213-003-1491-1 |
0.791 |
|
2003 |
Dong Y, White FJ. Dopamine D1-class receptors selectively modulate a slowly inactivating potassium current in rat medial prefrontal cortex pyramidal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 2686-95. PMID 12684454 DOI: 10.1523/Jneurosci.23-07-02686.2003 |
0.627 |
|
2002 |
Hu XT, Koeltzow TE, Cooper DC, Robertson GS, White FJ, Vezina P. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens. Synapse (New York, N.Y.). 45: 159-70. PMID 12112395 DOI: 10.1002/Syn.10095 |
0.834 |
|
2002 |
Zhang XF, Cooper DC, White FJ. Repeated cocaine treatment decreases whole-cell calcium current in rat nucleus accumbens neurons. The Journal of Pharmacology and Experimental Therapeutics. 301: 1119-25. PMID 12023545 DOI: 10.1124/jpet.301.3.1119 |
0.719 |
|
2001 |
Brandon CL, Marinelli M, Baker LK, White FJ. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 651-61. PMID 11682248 DOI: 10.1016/S0893-133X(01)00281-0 |
0.806 |
|
2001 |
White FJ. Neurobiology. Dopamine receptors get a boost. Nature. 411: 35, 37-8. PMID 11333962 DOI: 10.1038/35075193 |
0.487 |
|
2001 |
White FJ, Cooper DC. The vicious cyclin of addiction. Nature Medicine. 7: 416-7. PMID 11283665 DOI: 10.1038/86480 |
0.628 |
|
2000 |
Marinelli M, White FJ. Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8876-85. PMID 11102497 DOI: 10.1523/Jneurosci.20-23-08876.2000 |
0.719 |
|
2000 |
Cooper DC, White FJ. L-type calcium channels modulate glutamate-driven bursting activity in the nucleus accumbens in vivo. Brain Research. 880: 212-8. PMID 11033010 DOI: 10.1016/S0006-8993(00)02868-7 |
0.593 |
|
2000 |
Li Y, White FJ, Wolf ME. Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. Psychopharmacology. 151: 175-83. PMID 10972463 DOI: 10.1007/S002130000454 |
0.728 |
|
2000 |
Peterson JD, Wolf ME, White FJ. Altered responsiveness of medial prefrontal cortex neurons to glutamate and dopamine after withdrawal from repeated amphetamine treatment. Synapse (New York, N.Y.). 36: 342-4. PMID 10819912 DOI: 10.1002/(Sici)1098-2396(20000615)36:4<342::Aid-Syn11>3.0.Co;2-9 |
0.771 |
|
2000 |
Koeltzow TE, White FJ, Vezina P. 703 Excitatory effect of cocaine in the nucleus accumbens: A potential relationship between dopamine receptor activation and drug seeking Drug and Alcohol Dependence. 60. DOI: 10.1016/S0376-8716(00)90006-1 |
0.572 |
|
1999 |
Li Y, Wolf ME, White FJ. The expression of cocaine sensitization is not prevented by MK-801 or ibotenic acid lesions of the medial prefrontal cortex. Behavioural Brain Research. 104: 119-25. PMID 11125730 DOI: 10.1016/S0166-4328(99)00060-1 |
0.65 |
|
1999 |
Li Y, Hu XT, Berney TG, Vartanian AJ, Stine CD, Wolf ME, White FJ. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse (New York, N.Y.). 34: 169-80. PMID 10523754 DOI: 10.1002/(SICI)1098-2396(19991201)34:3<169::AID-SYN1>3.0.CO;2-C |
0.826 |
|
1999 |
Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, Caron MG. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nature Neuroscience. 2: 649-55. PMID 10404198 DOI: 10.1038/10204 |
0.807 |
|
1999 |
Xu M, Koeltzow TE, Cooper DC, Tonegawa S, White FJ. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse (New York, N.Y.). 31: 210-5. PMID 10029239 DOI: 10.1002/(Sici)1098-2396(19990301)31:3<210::Aid-Syn6>3.0.Co;2-0 |
0.811 |
|
1999 |
White FJ. DOPAMINE-GLUTAMATE INTERACTIONS IN COCAINE SENSITIZATION Behavioural Pharmacology. 10: S100. DOI: 10.1097/00008877-199908001-00254 |
0.431 |
|
1998 |
Henry DJ, Hu XT, White FJ. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology. 140: 233-42. PMID 9860115 DOI: 10.1007/s002130050762 |
0.632 |
|
1998 |
White FJ, Kalivas PW. Neuroadaptations involved in amphetamine and cocaine addiction. Drug and Alcohol Dependence. 51: 141-53. PMID 9716936 DOI: 10.1016/S0376-8716(98)00072-6 |
0.502 |
|
1998 |
Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, ... ... White FJ, et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (New York, N.Y.). 281: 838-42. PMID 9694658 DOI: 10.1126/Science.281.5378.838 |
0.703 |
|
1998 |
White FJ. Nicotine addiction and the lure of reward. Nature Medicine. 4: 659-60. PMID 9623965 DOI: 10.1038/nm0698-659 |
0.341 |
|
1998 |
White FJ. Cocaine and the serotonin saga. Nature. 393: 118-9. PMID 9603514 DOI: 10.1038/30105 |
0.491 |
|
1998 |
Koeltzow TE, Xu M, Cooper DC, Hu XT, Tonegawa S, Wolf ME, White FJ. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 2231-8. PMID 9482807 DOI: 10.1523/Jneurosci.18-06-02231.1998 |
0.812 |
|
1998 |
Zhang XF, Hu XT, White FJ. Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 488-98. PMID 9412525 DOI: 10.1523/Jneurosci.18-01-00488.1998 |
0.797 |
|
1998 |
White FJ, Joshi A, Koeltzow TE, Hu XT. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 26-40. PMID 9408916 DOI: 10.1016/S0893-133X(97)00093-6 |
0.841 |
|
1998 |
White FJ, Hu XT, Zhang XF. Neuroadaptations in nucleus accumbens neurons resulting from repeated cocaine administration. Advances in Pharmacology (San Diego, Calif.). 42: 1006-9. PMID 9328068 DOI: 10.1016/S1054-3589(08)60917-5 |
0.79 |
|
1998 |
Hansen JB, Fink-Jensen A, Christensen BV, Grønvald FC, Jeppesen L, Mogensen JP, Nielsen EB, Scheideler MA, White FJ, Zhang XF. Mesolimbic selective antipsychotic arylcarbamates European Journal of Medicinal Chemistry. 33: 839-858. DOI: 10.1016/S0223-5234(99)80009-9 |
0.397 |
|
1997 |
Johnston RE, Hu XT, White FJ, Becker JB. Intrastriatal grafts of fetal ventral mesencephalic tissue restore quantitative and qualitative D1/D2 dopamine receptor synergism in the striatum. Restorative Neurology and Neuroscience. 11: 13-20. PMID 21551524 DOI: 10.3233/RNN-1997-111202 |
0.454 |
|
1997 |
Li Y, Vartanian AJ, White FJ, Xue CJ, Wolf ME. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology. 134: 266-76. PMID 9438676 DOI: 10.1007/s002130050449 |
0.68 |
|
1997 |
Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM, Graybiel AM, White FJ, Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron. 19: 837-48. PMID 9354330 DOI: 10.1016/S0896-6273(00)80965-4 |
0.807 |
|
1997 |
White FJ, Hu XT, Zhang XF. DA D2 receptors in the ventral striatum: multiple effects or receptor subtypes? Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 17: 91-5. PMID 9201729 DOI: 10.1016/0924-977X(96)87405-0 |
0.395 |
|
1997 |
Zhang XF, Hu XT, White FJ, Wolf ME. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. The Journal of Pharmacology and Experimental Therapeutics. 281: 699-706. PMID 9152375 |
0.677 |
|
1997 |
Hu XT, White FJ. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors. Neuroscience Letters. 224: 61-5. PMID 9132692 DOI: 10.1016/S0304-3940(97)13443-7 |
0.794 |
|
1996 |
Cunningham KA, Henriksen SJ, Paris JM, Williams JT, White FJ. Electrophysical analyses of psychostimulant drug actions: from the slice to the awake animal. Nida Research Monograph. 162: 76-8. PMID 9066820 |
0.453 |
|
1996 |
Xu M, Hu XT, Cooper DC, White FJ, Tonegawa S. A genetic approach to study mechanisms of cocaine action. Annals of the New York Academy of Sciences. 801: 51-63. PMID 8959023 DOI: 10.1111/j.1749-6632.1996.tb17431.x |
0.734 |
|
1996 |
White FJ. Synaptic regulation of mesocorticolimbic dopamine neurons. Annual Review of Neuroscience. 19: 405-36. PMID 8833449 DOI: 10.1146/annurev.ne.19.030196.002201 |
0.514 |
|
1996 |
Hu XT, White FJ. Glutamate receptor regulation of rat nucleus accumbens neurons in vivo. Synapse (New York, N.Y.). 23: 208-18. PMID 8807749 DOI: 10.1002/(SICI)1098-2396(199607)23:3<208::AID-SYN10>3.0.CO;2-V |
0.399 |
|
1995 |
Wachtel SR, White FJ. The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons. Neuroscience Letters. 199: 13-6. PMID 8584215 DOI: 10.1016/0304-3940(95)12025-Y |
0.606 |
|
1995 |
Jeziorski M, White FJ. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. European Journal of Pharmacology. 275: 235-44. PMID 7768290 DOI: 10.1016/0014-2999(94)00779-7 |
0.568 |
|
1995 |
White FJ, Hu XT, Zhang XF, Wolf ME. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. The Journal of Pharmacology and Experimental Therapeutics. 273: 445-54. PMID 7714800 |
0.696 |
|
1995 |
Henry DJ, White FJ. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 6287-99. PMID 7666211 |
0.536 |
|
1994 |
Jeziorski M, White FJ, Wolf ME. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse (New York, N.Y.). 16: 137-47. PMID 8197575 DOI: 10.1002/syn.890160207 |
0.575 |
|
1994 |
Wolf ME, White FJ, Hu XT. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 1735-45. PMID 8126567 DOI: 10.1523/Jneurosci.14-03-01735.1994 |
0.714 |
|
1994 |
Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell. 79: 945-55. PMID 8001143 DOI: 10.1016/0092-8674(94)90026-4 |
0.853 |
|
1994 |
Hu XT, White FJ. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Synapse (New York, N.Y.). 17: 43-61. PMID 7913772 DOI: 10.1002/syn.890170106 |
0.766 |
|
1994 |
Wolf ME, Xue CJ, White FJ, Dahlin SL. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Research. 666: 223-31. PMID 7882032 DOI: 10.1016/0006-8993(94)90776-5 |
0.715 |
|
1993 |
Wolf ME, White FJ, Hu XT. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behavioural Pharmacology. 4: 429-442. PMID 11224212 DOI: 10.1097/00008877-199308000-00017 |
0.722 |
|
1993 |
White FJ, Hu XT, Henry DJ. Electrophysiological effects of cocaine in the rat nucleus accumbens: microiontophoretic studies. The Journal of Pharmacology and Experimental Therapeutics. 266: 1075-84. PMID 8355182 |
0.37 |
|
1993 |
Ackerman JM, Johansen PA, Clark D, White FJ. Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons. The Journal of Pharmacology and Experimental Therapeutics. 265: 963-70. PMID 8098768 |
0.382 |
|
1993 |
Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. The Journal of Pharmacology and Experimental Therapeutics. 264: 249-55. PMID 8093727 |
0.668 |
|
1993 |
Wolf ME, White FJ, Hu XT. Behavioral sensitization to MK-801 (dizocilpine) neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system Behavioural Pharmacology. 4: 429-442. |
0.37 |
|
1992 |
Hu XT, White FJ. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Synapse (New York, N.Y.). 10: 206-16. PMID 1532677 DOI: 10.1002/syn.890100304 |
0.544 |
|
1992 |
Henry DJ, Wise RA, Rompré PP, White FJ. Acute depolarization block of A10 dopamine neurons: interactions of morphine with dopamine antagonists. Brain Research. 596: 231-7. PMID 1467986 DOI: 10.1016/0006-8993(92)91552-P |
0.538 |
|
1992 |
Ackerman JM, White FJ. Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine. European Journal of Pharmacology. 218: 171-3. PMID 1397028 DOI: 10.1016/0014-2999(92)90161-V |
0.557 |
|
1992 |
Wachtel SR, Brooderson RJ, White FJ. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology. 109: 41-8. PMID 1365670 DOI: 10.1007/BF02245478 |
0.552 |
|
1992 |
Wachtel SR, White FJ. The effect of continuous and repeated administration of D1 dopamine receptor antagonist on midbrain dopamine neurons. Neurochemistry International. 20: 129S-133S. PMID 1365411 DOI: 10.1016/0197-0186(92)90225-G |
0.595 |
|
1992 |
Hu XT, Brooderson RJ, White FJ. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum. Neuroscience. 50: 137-47. PMID 1357592 DOI: 10.1016/0306-4522(92)90388-I |
0.543 |
|
1991 |
Henry DJ, White FJ. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. The Journal of Pharmacology and Experimental Therapeutics. 258: 882-90. PMID 1890623 |
0.545 |
|
1991 |
Johansen PA, Hu XT, White FJ. Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. Journal of Neural Transmission. General Section. 86: 97-113. PMID 1683241 DOI: 10.1007/BF01250571 |
0.494 |
|
1990 |
White FJ. Electrophysiological basis of the reinforcing effects of cocaine. Behavioural Pharmacology. 1: 303-315. PMID 11175415 |
0.344 |
|
1990 |
Ackerman JM, White FJ. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neuroscience Letters. 117: 181-7. PMID 2290614 DOI: 10.1016/0304-3940(90)90141-U |
0.555 |
|
1990 |
Brooderson RJ, White FJ, Galloway MP. Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors. Synapse (New York, N.Y.). 6: 395-7. PMID 2287994 DOI: 10.1002/syn.890060412 |
0.741 |
|
1990 |
White FJ, Hu XT, Brooderson RJ. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists. European Journal of Pharmacology. 191: 497-9. PMID 1982272 DOI: 10.1016/0014-2999(90)94188-4 |
0.543 |
|
1990 |
Hu XT, Wachtel SR, Galloway MP, White FJ. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2318-29. PMID 1973947 DOI: 10.1523/Jneurosci.10-07-02318.1990 |
0.746 |
|
1989 |
Exner M, Furmidge LJ, White FJ, Clark D. Inhibitory effects of partial D2 dopamine receptor agonists on the d-amphetamine discriminative cue. Behavioural Pharmacology. 1: 101-111. PMID 11175393 |
0.474 |
|
1989 |
Jeziorski M, White FJ. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Synapse (New York, N.Y.). 4: 267-80. PMID 2603146 DOI: 10.1002/syn.890040403 |
0.493 |
|
1989 |
Henry DJ, Greene MA, White FJ. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. The Journal of Pharmacology and Experimental Therapeutics. 251: 833-9. PMID 2557418 |
0.511 |
|
1989 |
Wachtel SR, Hu XT, Galloway MP, White FJ. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse (New York, N.Y.). 4: 327-46. PMID 2532422 DOI: 10.1002/syn.890040409 |
0.736 |
|
1988 |
Einhorn LC, Johansen PA, White FJ. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 100-12. PMID 3339402 |
0.481 |
|
1988 |
White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacology, Biochemistry, and Behavior. 30: 189-93. PMID 2902644 DOI: 10.1016/0091-3057(88)90442-X |
0.462 |
|
1988 |
Johansen PA, Clarkl D, White FJ. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence. Life Sciences. 43: 515-24. PMID 2900459 DOI: 10.1016/0024-3205(88)90153-1 |
0.366 |
|
1988 |
Wachtel SR, White FJ. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. The Journal of Pharmacology and Experimental Therapeutics. 244: 410-6. PMID 2891845 |
0.345 |
|
1988 |
Henry DJ, White FJ. New potential antipsychotic drug BMY 20661: A profile of its effects on midbrain dopamine neurons Drug Development Research. 12: 211-220. |
0.378 |
|
1987 |
White FJ. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. European Journal of Pharmacology. 135: 101-5. PMID 3494620 DOI: 10.1016/0014-2999(87)90764-3 |
0.472 |
|
1987 |
Clark D, White FJ. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse (New York, N.Y.). 1: 347-88. PMID 2971273 DOI: 10.1002/syn.890010408 |
0.403 |
|
1987 |
O'Brien DP, White FJ. Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: relationship to A10 dopamine cell activity. European Journal of Pharmacology. 142: 343-54. PMID 2892684 DOI: 10.1016/0014-2999(87)90072-0 |
0.376 |
|
1986 |
White FJ. Electrophysiological investigations of the D-1 dopamine receptor. Clinical Neuropharmacology. 9: 29-31. PMID 2952270 |
0.454 |
|
1986 |
White FJ, Wang RY. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat. Neuropharmacology. 25: 995-1001. PMID 2877417 DOI: 10.1016/0028-3908(86)90193-0 |
0.324 |
|
1986 |
White FJ, Wang RY. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 6: 274-80. PMID 2868077 |
0.503 |
|
1985 |
Wang RY, White FJ. Electrophysiological effects of cholecystokinin: central dopaminergic systems. Progress in Clinical and Biological Research. 192: 95-103. PMID 4080721 |
0.392 |
|
1985 |
Wang RY, White FJ, Voigt MM. Interactions of cholecystokinin and dopamine in the nucleus accumbens. Annals of the New York Academy of Sciences. 448: 352-60. PMID 2862829 DOI: 10.1111/J.1749-6632.1985.Tb29930.X |
0.37 |
|
1985 |
White FJ, Wang RY. Effects of chronic treatment with cholecystokinin on midbrain dopamine neurons Annals of the New York Academy of Sciences. 682-684. |
0.37 |
|
1984 |
White FJ, Wang RY. A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sciences. 34: 1161-70. PMID 6708722 DOI: 10.1016/0024-3205(84)90088-2 |
0.398 |
|
1984 |
White FJ, Wang RY. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. The Journal of Pharmacology and Experimental Therapeutics. 231: 275-80. PMID 6491980 |
0.465 |
|
1984 |
White FJ, Wang RY. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Research. 309: 283-92. PMID 6478223 DOI: 10.1016/0006-8993(84)90594-8 |
0.383 |
|
1984 |
White FJ, Wang RY. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons. Brain Research. 300: 161-6. PMID 6145498 DOI: 10.1016/0006-8993(84)91352-0 |
0.414 |
|
1984 |
Wang RY, White FJ. PHARMACOLOGICAL CHARACTERIZATION OF A 10 DOPAMINE AUTORECEPTORS Clinical Neuropharmacology. 7: S39. DOI: 10.1097/00002826-198406001-00038 |
0.413 |
|
1983 |
White FJ, Wang RY. Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat. Neuropharmacology. 22: 669-76. PMID 6888664 DOI: 10.1016/0028-3908(83)90089-8 |
0.355 |
|
1983 |
White FJ, Holohean AM, Appel JB. Antagonism of a behavioral effect of LSD and lisuride in the cat. Psychopharmacology. 80: 83-4. PMID 6408677 DOI: 10.1007/BF00427501 |
0.588 |
|
1983 |
White FJ, Wang RY. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science (New York, N.Y.). 221: 1054-7. PMID 6136093 |
0.316 |
|
1982 |
Appel JB, White FJ, Holohean AM. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures. Neuroscience and Biobehavioral Reviews. 6: 529-36. PMID 7177512 DOI: 10.1016/0149-7634(82)90036-7 |
0.487 |
|
1982 |
Nielsen EB, White FJ, Holohean AM, Callahan PM, Appel JB. Behavioral and biochemical evidence for serotonergic actions of tetrahydro-beta-carbolines. Life Sciences. 31: 2433-9. PMID 7154844 DOI: 10.1016/0024-3205(82)90747-0 |
0.468 |
|
1982 |
Holohean AM, White FJ, Appel JB. Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids. European Journal of Pharmacology. 81: 595-602. PMID 7117388 DOI: 10.1016/0014-2999(82)90349-1 |
0.558 |
|
1982 |
White FJ, Appel JB. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride. The Journal of Pharmacology and Experimental Therapeutics. 221: 421-7. PMID 7077537 |
0.532 |
|
1982 |
White FJ, Appel JB. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions. Science (New York, N.Y.). 216: 535-7. PMID 7071600 |
0.547 |
|
1982 |
White FJ, Appel JB. Training dose as a factor in LSD-saline discrimination. Psychopharmacology. 76: 20-5. PMID 6805003 DOI: 10.1007/BF00430748 |
0.459 |
|
1981 |
White FJ, Holohean AM, Appel JB. Lack of specificity of an animal behavior model for hallucinogenic drug action. Pharmacology, Biochemistry, and Behavior. 14: 339-43. PMID 7232460 DOI: 10.1016/0091-3057(81)90400-7 |
0.512 |
|
1981 |
White FJ, Appel JB. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology. 73: 110-5. PMID 6785800 DOI: 10.1007/BF00429199 |
0.541 |
|
1980 |
White FJ, Simmons MA, West KB, Holohean AM, Appel JB. The effect of serotonin depletion on the discriminability of LSD. Pharmacology, Biochemistry, and Behavior. 13: 569-74. PMID 6449014 DOI: 10.1016/0091-3057(80)90282-8 |
0.435 |
|
1979 |
Poling AD, White FJ, Appel JB. Discriminative stimulus properties of phencyclidine. Neuropharmacology. 18: 459-63. PMID 460541 DOI: 10.1016/0028-3908(79)90070-4 |
0.359 |
|
1979 |
White FJ, Appel JB, Kuhn DM. Discriminative stimulus properties of quipazine: direct serotonergic mediation. Neuropharmacology. 18: 143-51. PMID 34803 DOI: 10.1016/0028-3908(79)90054-6 |
0.581 |
|
1978 |
Kuhn DM, White FJ, Appel JB. The discriminative stimulus properties of LSD: mechanisms of action. Neuropharmacology. 17: 257-63. PMID 652138 DOI: 10.1016/0028-3908(78)90109-0 |
0.57 |
|
1977 |
White F, Kuhn D, Appel J. Discriminative stimulus properties of quipazine Neuropharmacology. 16: 827-832. DOI: 10.1016/0028-3908(77)90144-7 |
0.561 |
|
1976 |
Kuhn DM, White FJ, Appel JB. Discriminable stimuli produced by hallucinogens. Psychopharmacology Communications. 2: 345-8. PMID 996285 |
0.573 |
|
Show low-probability matches. |